Additional file 2 of The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial

Name: Additional file 2 of The effect of EMPAgliflozin on markers of inflammation in patients with concomitant type 2 diabetes mellitus and Coronary ARtery Disease: the EMPA-CARD randomized controlled trial
Creator: Chiti, Hossein; Gohari, Sepehr; Dadashi, Mohsen; Tayaranian, Mohammadreza; Arsang-Jang, Shahram; Fathi, Mojtaba; Ismail-Beigi, Faramarz; Muhammadi, Muhammad Javad; Mahjani, Mahsa; Ghobadian, Bijan; Reshadmanesh, Tara; Ghanbari, Samin; Mahmoodian, Reyhaneh; Gohari, Sheida; Taheri, Homa; Ahangar, Hassan; Asgari, Atieh; Karbalaee-Hasani, Amir; Moharrami, Mehdi; Khodabandehloo, Hadi
Published: 2022-11-18T00:00:00+08:00